Back

Lp(a) as therapeutic target: Now and in the future.

28 August 2021 (09:20 - 09:30)
Organised by:
Congress Presentation Part of: Lp(a): From CV risk marker to therapeutic target Risk Factors and Prevention Open Access ESC Congress 2021 - The Digital Experience

About the speaker

Photo
Professor Erik Stroes

AmsterdamUMC location AMC, Amsterdam (Netherlands (The))

2 More presentations in this session

Presentation thumbnail
Why focus on Lp(a) in cardiology?
Professor N. Sattar (Glasgow, GB)
Video
Presentation thumbnail
Understanding the increased cardiovascular risk of high Lp(a) levels.
Professor F. Kronenberg (Innsbruck, AT)
Video

Access the full session

Session thumbnail
Lp(a): From CV risk marker to therapeutic target
Video

The Event

Event poster

ESC Congress 2021 - The Digital Experience

28 August 2021 09:20 CET
You may be interested in
thumbnail
Webinar
Lipoprotein(a): current role and future perspectives in cardiovascular medicine
31 October 2025
thumbnail
Congress Presentation
GAELp(a): National Registry on Lp(a) and Cardiovascular Risk in Argentina
1 September 2025
thumbnail
Congress Presentation
OCEAN(a)-DOSE Extension
26 August 2023
thumbnail
Congress Presentation
Review on clinical strategies for managing patients with elevated Lp(a): Cost-effectiveness of Lp(a) testing and awareness of lifestyle changes via Public Health Policy in absence of targeted therapy
24 June 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources